CYP11B2 and pseudohypoaldosteronism type 1: Isolated hypoaldosteronism due to novel compound heterozygous mutations of the CYP11B2 gene and PHA type 1 due to a novel heterozygous mutation of NR3C2 gene each occurred in one patient.